ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
129.011,08
-0,24%
S&P 500
5.646,03
0,26%
US Dollar vs BRL
5,4517
0,06%
Bitcoin
64.534,01
-0,49%
Brent Oil
83,50
-1,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. (HSP)

  7. (HSP) Notícias

HSP

Hospira (HSP)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:HSP
DataHoraFonteTítuloCódigoCompanhia
27/03/201510:00PR Newswire (US)Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalenc...NYSE:HSP
23/03/201518:44The Motley FoolThis Market Could Grow 6250% in 10 YearsNYSE:HSP
23/03/201508:02The Motley Fool3 Big Pharma Stocks Wall Street Is Wrong AboutNYSE:HSP
20/03/201517:18Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:HSP
20/03/201517:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:HSP
06/03/201513:39PR Newswire (US)Hospira Statement on FDA Approval of the First Biosimilar in the United StatesNYSE:HSP
05/03/201519:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:HSP
27/02/201520:20Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NYSE:HSP
27/02/201518:07Edgar (US Regulatory)Current Report Filing (8-k)NYSE:HSP
25/02/201520:15Dow Jones NewsGeneric Copies of Remicade Go on Sale in EuropeNYSE:HSP
23/02/201513:06GlobeNewswire Inc.UPDATE - INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of Hospira Inc. of Class Action Against the Board of the Co...NYSE:HSP
19/02/201509:07PR Newswire (US)Inflectra™ (infliximab) patient registry reports interim results in the treatment of inflammatory bowel diseaseNYSE:HSP
18/02/201517:34Business WireHOSPIRA, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of BuyoutNYSE:HSP
17/02/201522:30Business WireHOSPIRA SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of the Hospira, Inc. (HSP) Board of Directors in ...NYSE:HSP
17/02/201512:40GlobeNewswire Inc.Investor Lawsuit Against Acquisition of Hospira, Inc. (HSP) Announced by Shareholders FoundationNYSE:HSP
16/02/201507:55PR Newswire (US)Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European marketsNYSE:HSP
13/02/201517:39PR Newswire (US)Lifshitz & Miller Law Firm Announces Investigation of E2open, Inc., Entropic Communications, Inc., Exelis, Inc., Hospira, Inc...NYSE:HSP
12/02/201520:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:HSP
12/02/201519:39Dow Jones NewsPainkiller in Short Supply Following Hospira Recall -- UpdateNYSE:HSP
12/02/201513:45Edgar (US Regulatory)Schedule 13g
(sc 13g)		NYSE:HSP
12/02/201511:21Dow Jones NewsHospira Profit Tops Expectations on Injectables StrengthNYSE:HSP
12/02/201511:03Edgar (US Regulatory)Annual Report (10-k)NYSE:HSP
12/02/201510:30PR Newswire (US)Hospira Reports Fourth-Quarter and Full-Year 2014 ResultsNYSE:HSP
11/02/201515:49Business WireSHAREHOLDER ALERT: The Law Offices of Vincent Wong Commences an Investigation of the Board of Directors of Hospira Inc. Regar...NYSE:HSP
10/02/201516:40Business WireSHAREHOLDER ALERT: Brower Piven Commences An Investigation Into The Proposed Sale Of Hospira, Inc. And Encourages Investors T...NYSE:HSP
10/02/201514:00PR Newswire (US)WeissLaw LLP: Hospira, Inc. Acquisition By Pfizer Inc. May Not Be In The Best Interest of HSP ShareholdersNYSE:HSP
10/02/201512:15PR Newswire (US)Pfenex And Hospira Announce Collaboration To Develop And Commercialize Proposed LUCENTIS® BiosimilarNYSE:HSP
09/02/201523:05PR Newswire (US)Harwood Feffer LLP Announces Investigation of Hospira, Inc.NYSE:HSP
09/02/201520:11PR Newswire (US)Hospira Cancels Previously Scheduled Conference Call to Discuss Fourth-Quarter and Full-Year 2014 ResultsNYSE:HSP
09/02/201519:46PR Newswire (US)Hospira Inc. Stockholders Encouraged to Contact Securities Law Firm about TakeoverNYSE:HSP
 Apresentando as notícias mais relevantes sobre:NYSE:HSP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HAGA3
HAGA ON
BOV
TELB4
TELEBRAS PN
BOV
AZEV4
AZEVEDO PN
BOV
GFSA3
GAFISA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AMER3
Americanas ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
COGN3
COGNA ON
BOV
LUPA3
LUPATECH ON
BOV
BOBR4
BOMBRIL PN
BOV
AMAR3
LOJAS MARISA ON
BOV
TCSA3
TECNISA ON
BOV
GOLL4
GOL PN
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados